Computed tomography radiomic feature analysis of thymic epithelial tumors: Differentiation of thymic epithelial tumors from thymic cysts and prediction of histological subtypes

被引:2
|
作者
Zhao, Wenya [1 ]
Ozawa, Yoshiyuki [2 ,3 ]
Hara, Masaki [4 ]
Okuda, Katsuhiro [5 ]
Hiwatashi, Akio [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Japan
[2] Fujita Hlth Univ, Sch Med, Dept Radiol, 1-98, Dengakugakubo, Kutsukake Cho, Toyoake, Aichi 4701192, Japan
[3] Fujita Hlth Univ, Okazaki Med Ctr, Dept Radiol, Okazaki, Japan
[4] Nagoya Johoku Teleradiol Clin, Nagoya, Japan
[5] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Japan
关键词
Thymoma; CT; Cyst; Mediastinum; texture analysis; LUNG-CANCER; INTRATHYMIC CYST; TEXTURE ANALYSIS; STAGING SYSTEM; CT; CLASSIFICATION; THYMOMA; BENIGN; SHAPE;
D O I
10.1007/s11604-023-01512-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo investigate the value of computed tomography (CT) radiomic feature analysis for the differential diagnosis between thymic epithelial tumors (TETs) and thymic cysts, and prediction of histological subtypes of TETs.Materials and MethodsTwenty-four patients with TETs (13 low-risk and 9 high-risk thymomas, and 2 thymic carcinomas) and 12 with thymic cysts were included in this study. For each lesion, the radiomic features of a volume of interest covering the lesion were extracted from non-contrast enhanced CT images. The Least Absolute Shrinkage and Selection Operator (Lasso) method was used for the feature selection. Predictive models for differentiating TETs from thymic cysts (model A), and high risk thymomas + thymic carcinomas from low risk thymomas (model B) were created from the selected features. The receiver operating characteristic curve was used to evaluate the effectiveness of radiomic feature analysis for differentiating among these tumors.ResultsIn model A, the selected 5 radiomic features for the model A were NGLDM_Contrast, GLCM_Correlation, GLZLM_SZLGE, DISCRETIZED_HISTO_Entropy_log2, and DISCRETIZED_HUmin. In model B, sphericity was the only selected feature. The area under the curve, sensitivity, and specificity of radiomic feature analysis were 1 (95% confidence interval [CI]: 1-1), 100%, and 100%, respectively, for differentiating TETs from thymic cysts (model A), and 0.76 (95%CI: 0.53-0.99), 64%, and 100% respectively, for differentiating high-risk thymomas + thymic carcinomas from low-risk thymomas (model B).ConclusionCT radiomic analysis could be utilized as a non-invasive imaging technique for differentiating TETs from thymic cysts, and high-risk thymomas + thymic carcinomas from low-risk thymomas.
引用
收藏
页码:367 / 373
页数:7
相关论文
共 50 条
  • [41] Searching for Novel Biomarkers in Thymic Epithelial Tumors: Immunohistochemical Evaluation of Hippo Pathway Components in a Cohort of Thymic Epithelial Tumors
    Palamaris, Kostas
    Levidou, Georgia
    Kordali, Katerina
    Masaoutis, Christos
    Rontogianni, Dimitra
    Theocharis, Stamatios
    BIOMEDICINES, 2023, 11 (07)
  • [42] Prognostic Significance and Reproducibility of Two Histological Classifications for Thymic Epithelial Tumors
    Roden, A. C.
    Yi, E. S.
    Bryant, S. C.
    Donovan, J. L.
    Lewis, J. E.
    Marks, R. S.
    Cassivi, S. D.
    Garces, Y. I.
    Aubry, M. C.
    LABORATORY INVESTIGATION, 2009, 89 : 360A - 360A
  • [43] Prognostic Significance and Reproducibility of Two Histological Classifications for Thymic Epithelial Tumors
    Roden, A. C.
    Yi, E. S.
    Bryant, S. C.
    Donovan, J. L.
    Lewis, J. E.
    Marks, R. S.
    Cassivi, S. D.
    Garces, Y. I.
    Aubry, M. C.
    MODERN PATHOLOGY, 2009, 22 : 360A - 360A
  • [44] CT Radiomic Features for Predicting Resectability and TNM Staging in Thymic Epithelial Tumors
    Araujo-Filho, Jose Arimateia Batista
    Mayoral, Maria
    Zheng, Junting
    Tan, Kay See
    Gibbs, Peter
    Shepherd, Annemarie Fernandes
    Rimner, Andreas
    Simone, Charles B.
    Riely, Gregory
    Huang, James
    Ginsberg, Michelle S.
    ANNALS OF THORACIC SURGERY, 2022, 113 (03): : 957 - 965
  • [45] Nivolumab treatment for metastatic thymic epithelial tumors
    Ak, Naziye
    Aydiner, Adnan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1710 - 1715
  • [46] Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors
    Ardeshir-Larijani, Fatemeh
    Schneider, Bryan P.
    Althouse, Sandra K.
    Radovich, Milan
    Masood, Ashiq
    Perna, Fabiana
    Salman, Huda
    Loehrer, Patrick J.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [47] Comprehensive molecular characterization of thymic epithelial tumors
    Kim, Chul
    Adeyelu, Tolulope Tosin
    Maniar, Rohan
    Farrell, Alex Patrick
    Zaemes, Jacob Peter
    Solzak, Jeffrey Peter
    Hancock, Bradley Allen
    Elliott, Andrew
    Micaily, Ida
    Nagasaka, Misako
    Nieva, Jorge J.
    Borghaei, Hossein
    Halmos, Balazs
    Ma, Patrick C.
    Radovich, Milan
    Badve, Sunil S.
    Loehrer, Patrick J., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Mesothelin expression in thymic epithelial tumors (TETs)
    Chen, Yuanbin
    Thomas, Anish
    Berman, Arlene W.
    Miettinen, Markku
    Hassan, Raffit
    Rajan, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Lymphogenous and hematogenous metastasis of thymic epithelial tumors
    Kondo, K
    Monden, Y
    ANNALS OF THORACIC SURGERY, 2003, 76 (06): : 1859 - 1864
  • [50] A New Testament for the Followers of Thymic Epithelial Tumors
    Abbas, Abbas El-Sayed
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2020, 15 (03) : 211 - 224